Introduction Heading
A heading tagline. It is slightly larger than the normal body text, which means it stands out. Plus it’s on a white background.
A Test Layer
Onco360 offers a single sourcing solution for the complex, multi-drug therapy regimens that make up today’s cutting-edge cancer treatment protocols. Through our OncoSource(r) program, we can provide comprehensive access to oral, injected, and infused oncology medications, including limited distribution drugs, adjunctive therapies, and administrative supplies.
Heading 3
Referring to Onco360 means you can rely on just one pharmacy to provide physicians and their patients with all of the medications included in the prescribed treatment plan. Whether oral, injected, or infused, Onco360 can handle it all. We call that Total Protocol Management(tm) and it is helping provide improved service, care, and outcomes by cutting down on clinical and benefit fragmentation.
Heading 4
- Item 1
- Item 2
The onco360 mission statement
Through a singular focus and dedication to the discipline of Oncology Pharmacy, we endeavor to provide the highest quality dispensing and clinical services to all of our customers, and most importantly, to every individual patient entrusted to our care.
We strive to advance the continuum of pharmaceutical cancer care, for each stakeholder involved in providing patient care by adhering to the three tenants of Onco360:
Access
Onco360 will always work diligently to help patients access their therapies
Focus
Onco360 will always focus on providing superior care to our patients, and superior service to
Compassion
Onco360 will always remember that patients are people first
IMBRUVICA Indications
IMBRUVICA (ibrutinib) has been approved by the FDA for the four following indications and is available for prescription order through Onco360.
Approved Indications | Recommended Dosage |
Chronic lymphocytic leukemia (CLL) patients who have received at least one prior treatment | 420 mg (three 140 mg capsules) orally once daily |
CLL patients with 17p deletion | 420 mg (three 140 mg capsules) orally once daily |
Waldenström’s macroglobulinemia (WM) patients | 420 mg (three 140 mg capsules) orally once daily |
Mantle cell lymphoma (MCL) patients who have received at least one prior treatment | 560 mg (four 140 mg capsules) orally once daily |
A Test Layer
Onco360 offers a single sourcing solution for the complex, multi-drug therapy regimens that make up today’s cutting-edge cancer treatment protocols. Through our OncoSource(r) program, we can provide comprehensive access to oral, injected, and infused oncology medications, including limited distribution drugs, adjunctive therapies, and administrative supplies.
This one is white
Referring to Onco360 means you can rely on just one pharmacy to provide physicians and their patients with all of the medications included in the prescribed treatment plan. Whether oral, injected, or infused, Onco360 can handle it all. We call that Total Protocol Management(tm) and it is helping provide improved service, care, and outcomes by cutting down on clinical and benefit fragmentation.
Heading 4
- Item 1
- Item 2
Rx Ordering, Tracking, and Shipping Made Easy
Onco360 provides easy ordering via fax, phone, or e-Prescribing, and all prescriptions are shipped free of charge. To begin referring, you can download our order forms at Onco360.com/Order and refer by:
Phone
987.123.4567
E-Subscribe
Send your e-Rx to Onco360 in Great Neck, NY 11021, or NPI# 1679618151 under the retail tab in your EMR/EHR or standalone e-prescribing application.
Product Spotlights
1. Physicians fax, call, or e-prescribe
Onco360 provides easy ordering via fax, phone, or e-Prescribing, and all prescriptions are shipped free of charge.
Fax
Fax a prescription to 877-662-6355
Phone
877.662.6633
E-Prescribe
e-Prescribe to Onco360 in Great Neck, NY 11021, or NPI# 1679618151 under the retail tab in your EMR/EHR or standalone e-prescribing application.
2. Verification process Lorem ipsum dolorum vatem inum vet un imnum.
- Investigate Patient Insurance Coverage
- Confirm Coverage
- Prior Authorization Process Support
- Collect Co-Payment When Required
- Source Financial Assistance Programs
- Bill Insurance for Rx
3. Delivery scheduled for treatment day – whenever you need it!
Onco360 Services
This is some text we will display at small screen sizes! This is some text we will display at small screen sizes! This is some text we will display at small screen sizes! This is some text we will display at small screen sizes!
Eligible patients who are prescribed IMBRUVICA may receive access support through the YOU&i Access Program. More information is available at: 877-877-3536 or at www.imbruvica.com/youandi.
For more information about IMBRUVICA, please visit IMBRUVICA.com.
Reference:
- www.imbruvica.com
- Imbruvica Prescribing Information
All rights in the product names, trade names, or logos of all third-party products, whether or not appearing with the registered trademark symbol, belong exclusively to their respective owners.
Test Content
Unmatched Availability
Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content.
Financial Assistance Support
Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content.
Coordination of Benefits
Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content.
Accessible Pharmacy
Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content.
Benefits Investigation
Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content.
Telephonic Nurses
Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content. Test content.
1 This is an example of the footnotes layer.
2 This is an example of the footnotes layer.
3 This is an example of the footnotes layer.